Craniosynostosis presents either as a nonsyndromic congenital anomaly or as a finding in nearly 200 genetic syndromes. Our previous genome-wide association study of sagittal nonsyndromic craniosynostosis identified associations with variants downstream from BMP2 and intronic in BBS9. Because no coding variants in BMP2 were identified, we hypothesized that conserved non-coding regulatory elements may alter BMP2 expression. In order to identify and characterize noncoding regulatory elements near BMP2, two conserved noncoding regions near the associated region on chromosome 20 were tested for regulatory activity with a Renilla luciferase assay.
INTRODUCTION
Craniosynostosis (CS) is a common congenital anomaly caused by the premature closure of one or more of the cranial vault sutures (Cohen, 2000; Johnson & Wilkie, 2011) . Mutations in at least twelve genes are found in syndromic craniosynostosis: EFNB1, ERF, FGFR1, FGFR2, FGFR3, MSX2, POR, PTH2R, RAB23, SIX2, TCF12, and TWIST1 (Lattanzi, Barba, Di Pietro, & Boyadjiev, 2017; PassosBueno, Serti Eacute, Jehee, Fanganiello, & Yeh, 2008) . Approximately, 80% of cases with craniosynostosis do not present with other birth defects or developmental delay and their etiology remains largely unknown.
The most common form of nonsyndromic craniosynostosis (NCS) involves the sagittal suture and comprises 40-58% of all NCS cases (Boyadjiev, 2007; Kimonis, Gold, Hoffman, Panchal, & Boyadjiev, 2007) with a prevalence of 1.9-2.3 per 10,000 live births (Hunter & Rudd, 1976; Lajeunie, Le Merrer, Bonaiti-Pellie, Marchac, & Renier, 1996) . In our previous genome-wide association study (GWAS) of sagittal NCS (sNCS), significant associations were observed in a 120 kilobase (kb) , respectively) (Justice et al., 2012) .
It is known that the formation and maintenance of the cranial sutures depends on osteoblast and osteocyte activity, which are controlled by several regulatory factors, including the bone morphogenetic proteins (BMPs). Recent animal studies have demonstrated that high levels of BMP2 in rabbits (Kinsella et al., 2011) and enhanced BMP2 signaling driven by BMPR1A in neural crest cells in mice (Komatsu et al., 2012) result in premature suture fusion.
Because no deleterious mutations were identified in the coding regions of BMP2 in the current study, we hypothesized that BMP2 expression is abnormally regulated in sNCS patients. To test this hypothesis, two conserved noncoding regions near BMP2 were tested for regulatory activity using a Renilla luciferase assay. Zebrafish transgenesis studies were then performed with the common (T) and risk (C) alleles at rs1884302 in order to investigate the regulatory activity of this noncoding variant.
MATERIALS AND METHODS

Luciferase assay
Two putative regulatory regions, R1 and R2, were identified and amplified from a sNCS patient (11028-1). R1 was 1,287 base pairs (bp) in length and located 357 kb downstream from BMP2 (GRCh37/hg19, chr20: 117, 119, 194 , with 100% identity between fragment and reference sequence); R2 was 711 bp in length and located 344 kb downstream of /hg19, chr20: 7,105,873-7,106,588, with 99 .5% identity between fragment and reference sequence) and encompassed rs1884302.
Patient (11028-1) was heterozygous (C/T) at rs1884302, and the R2 C allele and R2 T allele fragments were identical in sequence except at rs1884302. The SacI restriction enzyme site was introduced at the 5′ end and the MluI restriction enzyme site was introduced at the 3′ end to the 
Zebrafish transgenesis
The R2 fragments containing the common and risk variants of rs1884302 were cloned in the zebrafish enhancer detection vector 
RESULTS
Luciferase assay
Two conserved regions (Supplementary Figure S1 ) identified in the associated region on chromosome 20 (Justice et al., 2012) were cloned 5′ upstream of a BMP2 promoter reporter construct (Figure 1a ). The first region tested (R1) was 1,287 bp long and in a DNase hypersensitive region with several potential transcription factor binding sites. The second region tested (R2), a 711 bp long fragment, encompassed rs1884302, the SNP with the strongest association to sNCS (Justice et al., 2012 ). An increase in luciferase reporter was observed for R1 (p = 0.03), relative to the empty control, although the difference was not significant at a nominal critical value of 0.01 (Figure 1b) . Both R2 fragments, with either the risk allele (C) or the common allele (T) at rs1884302, had higher expression levels of the luciferase reporter relative to the control; and the risk allele (C), which was over-transmitted in our sNCS cohort, had higher expression than that of the common allele (T). The expression of the luciferase reporter for the R2 fragment with the C allele was highly significant (p = 0.0016) whereas the R2 T allele fragment was only marginally significant (p = 0.045) at a nominal critical level of 0.05. However, the two allele fragments did not differ significantly in their modulation of the promoter activity (p = 0.16), most likely due to the relatively small sample size, although the trend for the expression levels was consistent with the risk allele (C) having the highest expression. After adjustment for multiple tests, only the risk allele (C) compared to the control remained significant at a critical value of 0.01.
Zebrafish transgenesis
A zebrafish transgenesis assay was performed to test the 711 bp R2 fragment for putative regulatory function in vivo using the ZED vector (Bessa et al., 2009 ), which contains insulators that minimize false positive expression due to position effects. The risk allele (C) and common allele (T) fragments were tested, and pronounced GFP expression in the head region for the transgenic fish with the C allele was observed, indicating the 711 bp fragment had regulatory function.
Because of the mosaic expression of GFP in the injected fish, stable lines were generated for both constructs by screening founders for germline transmission. These F1 adults were outcrossed and GFP expression was observed in the F2 progeny during embryogenesis.
Progeny were evaluated from five founders: two founders for the C allele construct (C1 and C2) and three founders for the T allele construct (T1, T2, and T3).
There was clear GFP expression in the C allele fish (progeny of C1 and C2; Figure 2a) , and no GFP in the progeny from two of the T allele fish founders (T1 and T2; Figure 2b ). There was some GFP expression in the progeny of the T3 fish (T allele), but the expression pattern was clearly different than that observed for the C allele fish (Figure 2 ). GFP expression in the C-allele fish occurred in the midbrain and hindbrain, while in the T allele fish from founder T3, GFP expression occurred in the midbrain-hindbrain boundary. Overall, the zebrafish transgenesis data suggests a regulatory role for the 711 bp fragment that is affected by the change from the T to the C allele at rs1884302.
DISCUSSION
Our results are consistent with the idea that regions near the BMP2 locus identified by our GWAS contain a regulatory element(s) for BMP2
expression. The luciferase assay results suggest that the rs1884302 SNP may itself be an enhancer that exerts a direct regulatory effect on BMP2. Although the only difference in sequence between the two R2 fragments tested in our luciferase assay was at rs1884302, other SNPs or copy number variants near rs1884302 may impact the expression of BMP2 independently from or in concert with this SNP.
The zebrafish transgenesis results suggest a role of the C allele at rs1884302 in the regulatory function of the 711 bp noncoding DNA fragment. This assay tests a potential regulatory function of defined DNA segments in an in vivo vertebrate model, however, due to its limitations, we were unable to make any conclusions on the regulation of endogenous BMP2 expression or its effect on osteogenesis of the skull vault that occurs at 27 days past fertilization (Quarto & Longaker, 2005) . Again, the only difference in sequence between the fragments used in transgenesis was at rs1884302. Although there appears to be no sequence conservation in this 711 bp fragment between humans and zebrafish, there is a 21 bp region which aligns perfectly in zebrafish, and is intronic to bmpr1ba (Supplementary Figure S2) .
Transcription factor binding sites (TFBS) created by a change to a C allele at rs1884392 were identified using MEME (Bailey et al., 2009) and TOMTOM (Gupta, Stamatoyannopoulos, Bailey, & Noble, 2007) .
One TFBS candidate binds RFX7, which plays an important role in the molecular cascade that controls ciliogenesis in the neural tube (Manojlovic, Earwood, Kato, Stefanovic, & Kato, 2014) . This is of interest because we identified a strong association in our sNCS GWAS to BBS9 ( (GRCh37/hg19, chr20: 7, 117, 119, 194) and R2 (GRCH37/ hg19, chr20: 7, 105, 106, 588) were cloned into the RE region. , 2012) . Another TFBS candidate binds SMAD3 and the finding that BMP2 stimulates the SMAD2/3 pathway (Wang et al., 2014 ) is consistent with the idea that increased BMP2 production is due to SMAD-signaling.
Our results suggest that over-activation of BMP2 signaling contributes to the molecular basis of sNCS. The noncoding SNP rs1884302 appears to act as an enhancer involved in regulation, with clear differences in expression dependent on the presence of the risk or common allele. These findings, as well as the reports of Gdp6 (Settle et al., 2003) , Bmp4 (Cooper et al., 2010) , Bmp3 (Schoenebeck et al., 2012) , and Bmpr1a (Komatsu et al., 2012) all involving craniosynostosis in animal models, suggest that the BMP signaling pathway plays a role in craniosynostosis. A recent study (Whitton et al., 2016) reported BMP2 RNA overexpression in five of six osteoblasts isolated from the fused sutures of sNCS cases, further indicating that BMP2 overexpression may be responsible for sNCS.
Due to high frequency of this allele in the population (0.328 in Europeans, www.1000genomes.org), it seems likely that the C allele at rs1884302 alone is not responsible for the phenotype, but that an interaction of this allele with other variant(s) may be responsible for the sNCS phenotype. A recent report found that seven percent of probands with midline NCS (sagittal and metopic NCS) had damaging mutations in SMAD6 with strikingly reduced penetrance, and that 14 out of 17 affected individuals also carried the C risk allele at rs1884302. None of the 10 parents with SMAD6 mutations and a T allele at rs1884302 showed evidence of craniosynostosis (Timberlake et al., 2016) . Because the frequency of the C risk allele is high, the finding of 14 affected carriers with a C risk allele could be due to chance. However, it does suggest a twolocus inheritance for some sNCS cases, which may require characterizing the regulatory region surrounding rs1884302 and screening probands for mutations in genes involved in the BMP2 signaling pathway. 
